Literature DB >> 25124953

Tethered vitreous seeds following intravitreal melphalan for retinoblastoma.

Jasmine H Francis1, Brian P Marr2, Scott E Brodie3, Yves Pierre Gobin4, David H Abramson2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25124953     DOI： 10.1001/jamaophthalmol.2014.436

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  5 in total

1.  Vitreous Disease in Retinoblastoma: Clinical Findings and Treatment.

Authors:  Jasmine H Francis; Larissa A Habib; David H Abramson
Journal:  Adv Ophthalmol Optom       Date:  2017-08

2.  Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds.

Authors:  David H Abramson; Xunda Ji; Jasmine H Francis; Federica Catalanotti; Scott E Brodie; Larissa Habib
Journal:  Br J Ophthalmol       Date:  2018-06-06       Impact factor: 4.638

3.  The Association between Intravitreal Steroids and Post-Injection Endophthalmitis Rates.

Authors:  Brian L VanderBeek; Sarah G Bonaffini; Liyuan Ma
Journal:  Ophthalmology       Date:  2015-08-15       Impact factor: 12.079

4.  INTRAVITREAL MELPHALAN AS SALVAGE THERAPY FOR REFRACTORY RETINAL AND SUBRETINAL RETINOBLASTOMA.

Authors:  Jasmine H Francis; Brian P Marr; Scott E Brodie; Pierre Gobin; Ira J Dunkel; David H Abramson
Journal:  Retin Cases Brief Rep       Date:  2016

5.  Cytopathological Evaluation of Ocular Surface and Needle Washings Following Intravitreal Melphalan Injections for Retinoblastoma.

Authors:  Jasmine H Francis; Ijah Mondesire-Crump; Brian P Marr; Scott E Brodie; David H Abramson
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2016-02-04       Impact factor: 1.402
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.